These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34856208)

  • 1. Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved.
    Martín Giménez VM; Chuffa LGA; Simão VA; Reiter RJ; Manucha W
    Life Sci; 2022 Jan; 288():120191. PubMed ID: 34856208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation.
    Martín Giménez VM; Reiter RJ; Manucha W
    Drug Discov Today; 2023 Jun; 28(6):103539. PubMed ID: 36828191
    [No Abstract]   [Full Text] [Related]  

  • 3. Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.
    Martín Giménez VM; Noriega SE; Kassuha DE; Fuentes LB; Manucha W
    Ther Adv Cardiovasc Dis; 2018 Jul; 12(7):177-190. PubMed ID: 29764302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rise and fall of anandamide: processes that control synthesis, degradation, and storage.
    Biringer RG
    Mol Cell Biochem; 2021 Jul; 476(7):2753-2775. PubMed ID: 33713246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors.
    de Morais H; de Souza CP; da Silva LM; Ferreira DM; Baggio CH; Vanvossen AC; Cristina de Carvalho M; da Silva-Santos JE; Bertoglio LJ; Cunha JM; Zanoveli JM
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1590-600. PubMed ID: 27544303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology of the endocannabinoids: far beyond anandamide.
    Pamplona FA; Takahashi RN
    J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anandamide in primary sensory neurons: too much of a good thing?
    Sousa-Valente J; Varga A; Ananthan K; Khajuria A; Nagy I
    Eur J Neurosci; 2014 Feb; 39(3):409-18. PubMed ID: 24494681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid anandamide has an anti-inflammatory effect on CCL2 expression in vascular smooth muscle cells.
    Pflüger-Müller B; Oo JA; Heering J; Warwick T; Proschak E; Günther S; Looso M; Rezende F; Fork C; Geisslinger G; Thomas D; Gurke R; Steinhilber D; Schulz M; Leisegang MS; Brandes RP
    Basic Res Cardiol; 2020 Apr; 115(3):34. PubMed ID: 32323032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids in nervous system health and disease: the big picture in a nutshell.
    Skaper SD; Di Marzo V
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3193-200. PubMed ID: 23108539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anandamide in Plasmodium Berghei-infected mice.
    Bobbala D; Alesutan I; Föller M; Huber SM; Lang F
    Cell Physiol Biochem; 2010; 26(3):355-62. PubMed ID: 20798520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
    DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
    J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.
    D'Argenio G; Valenti M; Scaglione G; Cosenza V; Sorrentini I; Di Marzo V
    FASEB J; 2006 Mar; 20(3):568-70. PubMed ID: 16403786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity.
    Grambow E; Strüder D; Klar E; Hinz B; Vollmar B
    Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.
    Jaggar SI; Hasnie FS; Sellaturay S; Rice AS
    Pain; 1998 May; 76(1-2):189-99. PubMed ID: 9696473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat.
    Rettori E; De Laurentiis A; Zorrilla Zubilete M; Rettori V; Elverdin JC
    Neuroimmunomodulation; 2012; 19(5):293-303. PubMed ID: 22777139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
    Hernangómez M; Mestre L; Correa FG; Loría F; Mecha M; Iñigo PM; Docagne F; Williams RO; Borrell J; Guaza C
    Glia; 2012 Sep; 60(9):1437-50. PubMed ID: 22653796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures.
    Manna SS; Umathe SN
    Epilepsy Res; 2012 Jun; 100(1-2):113-24. PubMed ID: 22386872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
    De Petrocellis L; Melck D; Palmisano A; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8375-80. PubMed ID: 9653194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
    Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
    Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction.
    Jackson AR; Nagarkatti P; Nagarkatti M
    PLoS One; 2014; 9(4):e93954. PubMed ID: 24699635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.